Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19

• Status: Recruiting
• Trial end date: 2021-03-20
• Target enrollment: 0
• Participant gender: All

Summary

Ivermectin showed a strong viricidal effect upon covid19 virus in vitro as proved by many authors according to many studies , covid virus stay in postnasal space for 4 days before starting general manifestation, so ivermectin mucoadhesive nanosuspension sprayed inside the nose and post nasal space may help in early management of covid19 and may play a great rule in prophylaxis as well

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: South Valley University
• Treatments: Ivermectin

Criteria

Inclusion Criteria:

• early covid19 pateints

Exclusion Criteria:

• children and pregnant women